SDC4 and diffuse scleroderma: Moreover, it has been reported that syndecan-4 is overexpressed in the fibroblasts of patients with diffuse systemic sclerosis, and reduces the ability of contract TGF-β-induced collagen matrix and ERK activation in dermal fibroblasts [26].